AGL 5.50 Decreased By ▼ -0.10 (-1.79%)
ANL 8.69 Decreased By ▼ -0.21 (-2.36%)
AVN 75.84 Decreased By ▼ -1.14 (-1.48%)
BOP 5.18 Decreased By ▼ -0.07 (-1.33%)
CNERGY 4.51 Decreased By ▼ -0.14 (-3.01%)
EFERT 81.09 Decreased By ▼ -0.13 (-0.16%)
EPCL 50.00 Decreased By ▼ -0.03 (-0.06%)
FCCL 12.53 Decreased By ▼ -0.63 (-4.79%)
FFL 5.52 Decreased By ▼ -0.18 (-3.16%)
FLYNG 6.95 Decreased By ▼ -0.15 (-2.11%)
FNEL 4.65 Decreased By ▼ -0.11 (-2.31%)
GGGL 8.58 Decreased By ▼ -0.22 (-2.5%)
GGL 14.25 Decreased By ▼ -0.35 (-2.4%)
HUMNL 5.59 Decreased By ▼ -0.08 (-1.41%)
KEL 2.54 Decreased By ▼ -0.09 (-3.42%)
LOTCHEM 27.98 Decreased By ▼ -0.67 (-2.34%)
MLCF 23.70 Decreased By ▼ -0.99 (-4.01%)
OGDC 71.64 Decreased By ▼ -0.87 (-1.2%)
PAEL 15.09 Decreased By ▼ -0.28 (-1.82%)
PIBTL 4.89 Decreased By ▼ -0.09 (-1.81%)
PRL 15.81 Decreased By ▼ -0.39 (-2.41%)
SILK 1.07 No Change ▼ 0.00 (0%)
TELE 8.94 Decreased By ▼ -0.26 (-2.83%)
TPL 7.03 Decreased By ▼ -0.22 (-3.03%)
TPLP 18.31 Decreased By ▼ -0.39 (-2.09%)
TREET 21.03 Decreased By ▼ -0.67 (-3.09%)
TRG 134.55 Decreased By ▼ -2.00 (-1.46%)
UNITY 16.63 Decreased By ▼ -0.39 (-2.29%)
WAVES 9.32 Decreased By ▼ -0.57 (-5.76%)
WTL 1.36 Decreased By ▼ -0.05 (-3.55%)
BR100 4,154 Decreased By -71 (-1.68%)
BR30 15,289 Decreased By -229.2 (-1.48%)
KSE100 41,613 Decreased By -537.4 (-1.28%)
KSE30 15,360 Decreased By -228.1 (-1.46%)

UK denies vaccine shortfall will slow lockdown easing plan

  • AstraZeneca's vaccine, developed with Oxford University, provides the bulk of Britain's campaign.
Published March 18, 2021
Follow us

LONDON: Britain insisted Thursday its plan to ease coronavirus lockdowns in the coming months remained on track, despite news that its vaunted vaccination programme faces a potential pause in April.

The state-run National Health Service in England has warned in a letter to local vaccination centres that doses will be "significantly constrained" from March 29 for four weeks.

The next phase of the inoculation campaign, covering people in their 40s, will have to be suspended until May, the letter said.

Reports said the problem was linked to a delay in getting five million jabs sourced from India by UK-based drugs giant AstraZeneca -- the same company whose supply issues have caused anger in the European Union.

"It's a very complex international supply chain and that does mean occasionally we will experience issues and that's what we've experienced right now," cabinet minister Robert Jenrick told Sky News.

But the government was sticking to its target of offering a first dose to every adult by the end of July, he said, after Britain on Wednesday said it had surpassed 25 million jabs delivered.

The government's phased easing of its third lockdown in England, which was imposed in January amid a winter surge in caseloads of Covid-19 and resulting deaths, hinges on the success of the inoculation drive.

"There's no reason to believe the roadmap is affected by this temporary shortage in supply," Jenrick stressed of the relaxation plan.

AstraZeneca's vaccine, developed with Oxford University, provides the bulk of Britain's campaign.

The company said its "UK domestic supply chain is not experiencing any disruption", but made no mention of possible problems in India or elsewhere.

Britain's current other vaccine provider is Pfizer, which denied any issues with its UK delivery schedule.

The supply issues are another headache for AstraZeneca after its jab was suspended in several EU countries, pending a review by the European Medicines Agency due later Thursday following isolated cases of blood clots and brain haemorrhages.

The EU meanwhile threatened on Wednesday to invoke emergency powers to block European exports of Covid-19 vaccines to ensure "reciprocity" with other suppliers, urging Britain to send Europe more jabs.

Britain reacted angrily to the threat, with Foreign Secretary Dominic Raab suggesting the bloc was engaging in "brinkmanship", and has dismissed any medical issues with the AstraZeneca vaccine.

Prime Minister Boris Johnson, 56, said on Wednesday he would take it vaccine "very shortly".

England's deputy chief medical officer Jonathan Van-Tam also pushed back at the AstraZeneca suspension in European countries including France, Germany and Italy.

"Vaccines don't save lives if they're in fridges. They only save lives if they're in arms," he said.


Comments are closed.

UK denies vaccine shortfall will slow lockdown easing plan

ECC approves wheat import of 450,000MT from Russia

Time to 'say no' to cartels, says PM, as energy bill touches $27bn

Rupee drops 0.10% against US dollar

UAE, Ukraine to start talks on bilateral trade deal

Oil prices rise after OPEC+ keeps output steady, Russian price cap imposed

Taliban acting defence minister holds talks with UAE president

Cotton arrival falls 40% year-on-year

Engro Corp to pursue potential investment opportunity in tower infrastructure sector

Big tax defaulters: FBR to auction off properties, trademarks

FBR set to fix minimum value for sugar supply